Tesser Rachel, Hess Derek B, Freedman Sharon F
Duke University Eye Center, Durham, North Carolina, USA.
J AAPOS. 2005 Aug;9(4):330-5. doi: 10.1016/j.jaapos.2005.04.004.
We sought to investigate the outcomes of children who underwent simultaneous intraocular lens (IOL) implant and glaucoma implant surgery.
Medical records of all patients who underwent simultaneous IOL implant and glaucoma implant surgery from January 1995 through August 2003 by a single surgeon were reviewed. Criteria for success included intraocular pressure </=22 mm Hg, or judged adequate for glaucoma severity, without vision loss or devastating complication.
The study included 9 eyes of 8 children who had a mean age of 7.6 years (range, 1-16) and a mean follow-up time of 21 months (range, 8.5-35 months) after simultaneous IOL (either cataract removal with primary IOL, 2 eyes; or secondary IOL implantation, 7 eyes), and glaucoma implant surgery (6 Baerveldt, 3 Ahmed). The indications for combined surgery fell into 3 basic categories: unilateral aphakia with glaucoma (4/9), anatomical features (such as shallow anterior chamber and/or vitreous in the pupillary plane) making an IOL helpful in positioning the tube away from corneal endothelium and/or vitreous (4/9), and unilateral traumatic cataract (1/9). Mean intraocular pressure for operated eyes was 29 mm Hg (range, 21-44) preoperatively and fell to 17 mm Hg (range, 11-22) at last follow up, P = 0.01. The mean number of glaucoma medications was 3.5 preoperatively (range, 2-5) versus 1.9 (range, 0-4) at last follow-up (p = NS). Complications (n = 5) were varied, only 2 of which required additional surgery. Eighty-nine percent (8/9) of patients met criteria for success at last follow-up.
Selected children can do well after combined glaucoma implant and IOL surgery, achieving both satisfactory glaucoma control and stable visual acuity.
我们试图研究接受同期人工晶状体(IOL)植入和青光眼植入手术的儿童的手术效果。
回顾了1995年1月至2003年8月间由同一位外科医生进行同期IOL植入和青光眼植入手术的所有患者的病历。成功标准包括眼压≤22mmHg,或根据青光眼严重程度判断为足够,且无视力丧失或严重并发症。
该研究纳入了8名儿童的9只眼,这些儿童的平均年龄为7.6岁(范围1 - 16岁),在同期进行IOL植入(2只眼为白内障摘除联合一期IOL植入,7只眼为二期IOL植入)和青光眼植入手术(6只眼植入Baerveldt,3只眼植入Ahmed)后,平均随访时间为21个月(范围8.5 - 35个月)。联合手术的适应证分为3个基本类别:单侧无晶状体眼合并青光眼(4/9)、解剖学特征(如浅前房和/或瞳孔平面的玻璃体)使IOL有助于将引流管放置在远离角膜内皮和/或玻璃体的位置(4/9)以及单侧外伤性白内障(1/9)。手术眼术前平均眼压为29mmHg(范围21 - 44mmHg),最后一次随访时降至17mmHg(范围11 - 22mmHg),P = 0.01。术前青光眼药物的平均使用数量为3.5种(范围2 - 5种),而最后一次随访时为1.9种(范围0 - 4种)(P = 无统计学意义)。并发症(n = 5)各不相同,其中只有2例需要再次手术。89%(8/9)的患者在最后一次随访时达到成功标准。
部分儿童在联合青光眼植入和IOL手术后效果良好,既能实现令人满意的青光眼控制,又能保持稳定的视力。